Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2362877
Max Phase: Preclinical
Molecular Formula: C29H38ClN3O6S
Molecular Weight: 592.16
Molecule Type: Small molecule
Associated Items:
ID: ALA2362877
Max Phase: Preclinical
Molecular Formula: C29H38ClN3O6S
Molecular Weight: 592.16
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CN([C@H](C)CO)C(=O)c2cc(NC(=O)C3CCCCC3)ccc2O[C@H]1CN(C)S(=O)(=O)c1cccc(Cl)c1
Standard InChI: InChI=1S/C29H38ClN3O6S/c1-19-16-33(20(2)18-34)29(36)25-15-23(31-28(35)21-8-5-4-6-9-21)12-13-26(25)39-27(19)17-32(3)40(37,38)24-11-7-10-22(30)14-24/h7,10-15,19-21,27,34H,4-6,8-9,16-18H2,1-3H3,(H,31,35)/t19-,20-,27+/m1/s1
Standard InChI Key: LFAAAGOOMGHFSS-DVHCVUMVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 592.16 | Molecular Weight (Monoisotopic): 591.2170 | AlogP: 4.40 | #Rotatable Bonds: 8 |
Polar Surface Area: 116.25 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.08 | CX LogD: 4.08 |
Aromatic Rings: 2 | Heavy Atoms: 40 | QED Weighted: 0.47 | Np Likeness Score: -1.18 |
1. PubChem BioAssay data set, |
2. Dockendorff C, Faloon PW, Pu J, Yu M, Johnston S, Bennion M, Penman M, Nieland TJ, Dandapani S, Perez JR, Munoz B, Palmer MA, Schreiber SL, Krieger M.. (2015) Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake., 25 (10): [PMID:25900219] [10.1016/j.bmcl.2015.03.073] |
Source(2):